JACQUES JM
VAN DONGEN
Investigador
Charité
Berlín, AlemaniaPublicaciones en colaboración con investigadores/as de Charité (20)
2019
-
Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS
Leukemia, Vol. 33, Núm. 9, pp. 2254-2265
-
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
Leukemia, Vol. 33, Núm. 9, pp. 2241-2253
2017
-
High-throughput immunogenetics for clinical and research applications in immunohematology: Potential and challenges
Journal of Immunology, Vol. 198, Núm. 10, pp. 3765-3774
2016
-
New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia
British Journal of Haematology, Vol. 172, Núm. 5, pp. 769-781
2013
-
The MLL recombinome of acute leukemias in 2013
Leukemia, Vol. 27, Núm. 11, pp. 2165-2176
2012
-
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations
Leukemia, Vol. 26, Núm. 10, pp. 2159-2171
-
The EuroClonality website: Information, education and support on clonality testing
Journal of Hematopathology, Vol. 5, Núm. 1-2, pp. 99-103
2010
2009
-
New insights to the MLL recombinome of acute leukemias
Leukemia, Vol. 23, Núm. 8, pp. 1490-1499
2007
-
Analysis of minimal residual disease by Ig/TCR gene rearrangements: Guidelines for interpretation of real-time quantitative PCR data
Leukemia
-
Childhood secondary ALL after ALL treatment
Leukemia, Vol. 21, Núm. 7, pp. 1431-1435
-
Improved reliability of lymphoma diagnostics via PCR-based clonality testing: - Report of the BIOMED-2 Concerted Action BHM4-CT98-3936
Leukemia, Vol. 21, Núm. 2, pp. 201-206
-
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936
Leukemia, Vol. 21, Núm. 2, pp. 215-221
-
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936
Leukemia, Vol. 21, Núm. 2, pp. 207-214
2006
-
Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia
Leukemia Research, Vol. 30, Núm. 1, pp. 98-102
-
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks
Leukemia, Vol. 20, Núm. 8, pp. 1385-1392
-
The MLL recombinome of acute leukemias
Leukemia, Vol. 20, Núm. 5, pp. 777-784
2005
-
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection
Clinical Cancer Research, Vol. 11, Núm. 21, pp. 7720-7727
1993
-
Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor α/β lineage: T cell receptor δ gene deletion mechanism affects multiple genes
Journal of Experimental Medicine, Vol. 177, Núm. 4, pp. 965-977
-
tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease
Leukemia, Vol. 7, Núm. 12, pp. 2004-2011